Hereditary elliptocytosis epidemiology and demographics

Revision as of 16:07, 21 September 2012 by Aarti Narayan (talk | contribs)
Jump to navigation Jump to search

Hereditary elliptocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary elliptocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary elliptocytosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary elliptocytosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary elliptocytosis epidemiology and demographics

CDC on Hereditary elliptocytosis epidemiology and demographics

Hereditary elliptocytosis epidemiology and demographics in the news

Blogs on Hereditary elliptocytosis epidemiology and demographics

Directions to Hospitals Treating Hereditary elliptocytosis

Risk calculators and risk factors for Hereditary elliptocytosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

  • The incidence of hereditary elliptocytosis is hard to determine, as many sufferers of the milder forms of the disorder are asymptomatic and their condition never comes to medical attention.
  • Around 90% of those with this disorder are thought to fall into the asymptomatic population.

Developed Countries

  • It is estimated that its incidence is between 3 and 5 per 10,000 in the USA

Developing Countries

  • Those of African and Mediterranean descent are of higher risk.
  • Some subtypes of hereditary elliptocytosis are significantly more prevalent in regions where malaria is endemic.
  • For example, in equatorial Africa its incidence approaches 160 per 10,000, and in Malayan natives its incidence is over 15% (1500-2000 per 10,000).

Sex

  • Being an almost wholly autosomal dominant disorder, there is no predilection towards either sex in hereditary elliptocytosis.
  • The most important exception to this rule of autosomal dominant inheritance is for a subtype of hereditary elliptocytosis called hereditary pyropoikilocytosis (HPP). This condition is autosomal recessive.

References

Template:WH Template:WS